Retractable Technologies is part of the healthcare sector and is in the medical instruments and equipment industry. The company CEO is Thomas J. Shaw. Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. It offers 1mL tuberculin; allergy antigen VanishPoint syringes.
Previous Intraday Performance:
The RVP shares had a previous change of -1.96% which opened at 0.69 and closed at 0.65. It moved to an intraday high of 0.69 and a low of 0.65.
Over the last five trading days, RVP shares returned -9.66% and in the past 30 trading days it returned -14.44%. Over three months, it changed -7.01%. In one year it has changed -28.18% and within that year its 52-week high was 1.34 and its 52-week low was 0.54. RVP stock is 20.15% above its 52 Week Low.
Our calculations result in a 200 day moving average of 0.72 and a 50 day moving average of 0.73. Right now, RVP stock is trading -9.41% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
The company has a market cap of $21.2m with 32.7m shares outstanding and a float of 13.2m shares. Trading volume was 60,738 shares and has experienced an average volume of 399,672 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for Retractable Technologies was -0.06 which ended on 31st of December 2018.
The next earnings report will be: 05-09-2019
The long-term trend of the EPS is an important number as it indicates the present value of Retractable Technologies; it is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but revenue growth has been -5.60% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 59.70% of insider ownership and 6.00% of institutional ownership. Short-interest was 10,336, which was 0.03% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.03. This stock has some short interest, but it might be normal and no need to worry if long the position.
I calculated the beta to be 0.31
Based on last reported financials, the company’s return on equity is -7.98%, return on assets is -5.46%, profit margin is -4.53%, price-to-sales is 0.85 and price-to-book is 0.87.
Company Score Card:
Results are out of six:
0 : Growth Expectations Result
6 : Financial Safety Result
0 : Past Performance Result
1 : Valuation Result
0 : Dividend Safety Result
1 : Overall Result